补肺纳肾法治疗慢性阻塞性肺疾病稳定期的临床疗效研究

Clinical observation on treating chronic obstructive pulmonary disease in stable stage by invigorating lung and kidney

目的:探析慢性阻塞性肺疾病稳定期患者用补肺纳肾法理论进行治疗的临床效果。方法:选取新疆喀什地区第二人民医院2017年8月至2018年8月间诊疗处于稳定期的慢性阻塞性肺疾病患者92例相关数据进行分析,根据患者接受治疗方案差异将其每组46例分为对照组与联合组,对照组患者接受常规慢性阻塞性肺疾病稳定期西医方案治疗,联合组患者联合补肺纳肾法。在治疗2个月后对患者相关临床指标进行评估并对比。结果:在临床疗效方面,对照组患者有效率为82.6%(38/46),联合组患者有效率为91.3%(42/46),联合组具显著优越性(P<0.05);在治疗前后对两组患者肺功能及炎性因子进行检测,两组均有所改善,联合组治疗后相关指标明显优于对照组且有统计学意义(P<0.05)。结论:对处于稳定期的慢性阻塞性肺疾病患者在常规对症治疗基础上联合补肺纳肾法能够进一步提高对患者相关临床指标的改善情况,疗效更为突出,值得临床推广。

Objective: To analyze the clinical effect of the treatment of patients with chronic obstructive pulmonary disease in the stable phase with the theory of Bufei Nashen. Methods: A total of 92 patients with chronic obstructive pulmonary disease who were in stable period from August 2017 to August 2018 were enrolled in the study. According to the difference in treatment plan,46 patients in each group were divided into control group and In the combined group,the control group received a stable Western medicine regimen for routine chronic obstructive pulmonary disease,and the combined group was treated with the supplemental lung and kidney method. The patient’s relevant clinical indicators were evaluated and compared after 2 months of treatment. Results: In terms of clinical efficacy,the effective rate was 82.6%( 38/46) in the control group and 91.3%( 42/46) in the combined group. The combination group had significant superiority( P<0.05); before and after treatment. The lung function and inflammatory factors were detected in both groups,and the two groups were improved. The related indexes in the combined group were significantly better than the control group( P<0.05). Conclusion: The combination of supplemental lung and kidney method on patients with chronic obstructive pulmonary disease in stable phase can improve the improvement of clinical indicators related to patients. The curative effect is more prominent and worthy of clinical promotion.